Johnson & Johnson (JNJ)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$154.80
Buy
$155.54
$0.88 (+0.57%)
Prices updated at 28 Nov 2024, 00:59 EST
| Prices minimum 15 mins delay
Prices in USD
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 68.82 |
| 2022 | 69.25 |
| 2021 | 70.28 |
| 2020 | 65.58 |
| 2019 | 66.42 |
| 2018 | 66.79 |
| 2017 | 66.72 |
| 2016 | 69.69 |
| 2015 | 69.27 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2024 | 4.31 |
| 2023 | 4.16 |
| 2022 | 4.91 |
| 2021 | 5.00 |
| 2020 | 5.20 |
| 2019 | 4.82 |
| 2018 | 4.33 |
| 2017 | 5.17 |
| 2016 | 4.50 |
| 2015 | 4.11 |
| 2014 | 4.03 |
Price/Forward earnings (YTD)
14.53
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | 19.81 |
| 2022 | 9.71 |
| 2021 | 11.70 |
| 2020 | 8.85 |
| 2019 | 9.73 |
| 2018 | 9.86 |
| 2017 | 0.87 |
| 2016 | 12.05 |
| 2015 | 11.68 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 2.44 |
| 2022 | 2.44 |
| 2021 | 2.46 |
| 2020 | 2.76 |
| 2019 | 2.65 |
| 2018 | 2.56 |
| 2017 | 2.61 |
| 2016 | 2.01 |
| 2015 | 1.88 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
